| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/03/2013 | US20130005669 Novel synthetic glycolipid and use thereof |
| 01/03/2013 | US20130005666 Reporter system for high throughput screening of compounds and uses thereof |
| 01/03/2013 | US20130005665 Macrogol 15 hydroxystearate formulations |
| 01/03/2013 | US20130005658 Micro-rna regulation in ischemia and ischemia-reperfusion injury |
| 01/03/2013 | US20130005655 Combination therapy using low-dose doxepin for the improvement of sleep |
| 01/03/2013 | US20130005650 Methods and compositions for treating diseases associated with pathogenic proteins |
| 01/03/2013 | US20130005643 Method for preparing nano-particles |
| 01/03/2013 | US20130004785 Paraben derivatives for preserving cellulosic materials |
| 01/03/2013 | US20130004651 Sustained drug release from body implants using nanoparticle-embedded polymeric coating materials |
| 01/03/2013 | US20130004601 Appetite regulating dietary supplement |
| 01/03/2013 | US20130004592 Pharmaceutical compositions for parenteral administration |
| 01/03/2013 | US20130004589 Divalent cation/anion pair containing compositions and methods for treating and/or preventing enzymatic irritation |
| 01/03/2013 | US20130004586 Biologically Efficacious Compositions, Articles of Manufacture and Processes for Producing and/or Using Same |
| 01/03/2013 | US20130004578 Solid Pharmaceutical Dosage Formulation |
| 01/03/2013 | US20130004577 Coated tablet |
| 01/03/2013 | US20130004576 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect |
| 01/03/2013 | US20130004575 Controlled release formulations using intelligent polymers |
| 01/03/2013 | US20130004573 Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride |
| 01/03/2013 | US20130004572 Stable pharmaceutical composition and methods of using same |
| 01/03/2013 | US20130004571 Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product |
| 01/03/2013 | US20130004570 Nutritional supplement for use under physiologically stressful conditions |
| 01/03/2013 | US20130004569 Oral antimicrobial pharmaceutical compositions |
| 01/03/2013 | US20130004568 Methods of treating hypertriglyceridemia |
| 01/03/2013 | US20130004567 Methods of treating hypertriglyceridemia |
| 01/03/2013 | US20130004566 Methods of treating hypertriglyceridemia |
| 01/03/2013 | US20130004563 Multiparticulate s-adenosylmethionine compositions and related methods |
| 01/03/2013 | US20130004562 Process for preparing purified nucleic acid and the use thereof |
| 01/03/2013 | US20130004559 Flat self-curling permeable sheet membrane |
| 01/03/2013 | US20130004557 Antimicrobial Resin Compositions |
| 01/03/2013 | US20130004555 Cosmetic Compositions Comprising Esters Based on 2-Propylheptanol |
| 01/03/2013 | US20130004554 Microalgae-Derived Compositions for Improving the Health and Appearance of Skin |
| 01/03/2013 | US20130004551 Biotinylated hexadecasaccharides, preparation and use thereof |
| 01/03/2013 | US20130004550 Sustained-release solid preparation for oral use |
| 01/03/2013 | US20130004546 Hydrogel of microspheres |
| 01/03/2013 | US20130004545 Slow release pharmaceutical compositions of iloperidone |
| 01/03/2013 | US20130004542 Composition |
| 01/03/2013 | US20130004533 Platelet-derived growth factor-bb production promotor, and mesenchymal stem cell production accelerator, stem cell stabilizer and dermal regenerator comprising the same |
| 01/03/2013 | US20130004526 Utilization of Dialkylfumarates |
| 01/03/2013 | US20130004523 Therapeutic compositions and methods for delivery of active agents cleavably linked to nanoparticles |
| 01/03/2013 | US20130004521 Targeting cancer stem cells |
| 01/03/2013 | US20130004520 Methods and materials related to hair pigmentation and cancer |
| 01/03/2013 | US20130004519 Smoci, tenascin-c and brain cancers |
| 01/03/2013 | US20130004518 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 01/03/2013 | US20130004517 Disc-1 pathway activators in the control of neurogenesis |
| 01/03/2013 | US20130004512 Nucleic acid molecules encoding bank1 splice variants |
| 01/03/2013 | US20130004511 Composition comprising inhibitors of irs-1 and of vegf |
| 01/03/2013 | US20130004509 BRAF Mutations Conferring Resistance to BRAF Inhibitors |
| 01/03/2013 | US20130004507 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
| 01/03/2013 | US20130004506 Method for treating pathologies associated with hypoxia using mif inhibitors |
| 01/03/2013 | US20130004502 Influenza targets |
| 01/03/2013 | US20130004495 Anti-ngf antibodies for the treatment of various disorders |
| 01/03/2013 | US20130004488 Anti-cancer agent delivery vehicles capable of improved loading |
| 01/03/2013 | US20130004482 Methods of Treating Breast Cancer with Anthracycline Therapy |
| 01/03/2013 | US20130004481 Anticancer therapy |
| 01/03/2013 | US20130004477 Methods for Treating Inflammation and Oxidative Stress Related Diseases |
| 01/03/2013 | US20130004467 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| 01/03/2013 | US20130004460 Silylated biomolecules |
| 01/03/2013 | US20130004458 Small Molecule Inhibitors of Retroviral Assembly and Maturation |
| 01/03/2013 | US20130004457 Hepatitis C Virus Inhibitors |
| 01/03/2013 | US20130004455 Poly(organophosphazene) composition for biomaterials |
| 01/03/2013 | US20130004453 Nylon-3 co-polymers and synthetic lung surfactant compositions containing same |
| 01/03/2013 | US20130004444 Composition containing at least one c7 sugar for alopecia treatment, cosmetic treatment of hair and nails, and care of hair, eyelashes, or nails |
| 01/03/2013 | US20130004436 Compositions and Methods of Treating and Preventing Lung Cancer and Lymphangioleiomyomatosis |
| 01/03/2013 | US20130004434 Gastroretentive, Extended Release Composition Of Therapeutic Agent |
| 01/03/2013 | US20130004428 Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| 01/03/2013 | US20130004427 Targeted dendrimer-drug conjugates |
| 01/03/2013 | US20130004426 Adenosine derivative formulations for medical imaging |
| 01/03/2013 | US20130004423 Polyazamacrocyclic compound, and a production method and a biomedical use therefor |
| 01/03/2013 | US20130004422 Benzothiazole derivative compounds, compositions and uses |
| 01/03/2013 | DE202012002792U1 Zusammensetzung für die nasale Applikation mit verbesserter Stabilität A composition for nasal administration having improved stability |
| 01/03/2013 | CA2877891A1 Process for preparing heparinoids and intermediates useful in the synthesis thereof |
| 01/03/2013 | CA2877102A1 Topical formulations including lipid microcapsule delivery vehicles and their uses |
| 01/03/2013 | CA2841158A1 Microrna-31 compositions and methods for use in autoimmune disease |
| 01/03/2013 | CA2840806A1 Novel salts of sitagliptin |
| 01/03/2013 | CA2840765A1 Multilayered dosage form |
| 01/03/2013 | CA2840733A1 Retinoid topical compositions and methods for treating skin conditions |
| 01/03/2013 | CA2840731A1 Alcaftadine for use in the treatment of urticaria |
| 01/03/2013 | CA2840643A1 Peripherally acting opioid compounds |
| 01/03/2013 | CA2840626A1 Methods of treating recurrent meibomian glands disorder and thereby decreasing the frequency of recurrence |
| 01/03/2013 | CA2840614A1 Methods for modulating kallikrein (klkb1) expression |
| 01/03/2013 | CA2840612A1 Method for treating eczema |
| 01/03/2013 | CA2840606A1 Oxazetidine derivatives, process for preparing them and use thereof in human medicine and in cosmetics |
| 01/03/2013 | CA2840574A1 Method for producing fine particles of aripiprazole anhydride crystals b |
| 01/03/2013 | CA2840571A1 High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis |
| 01/03/2013 | CA2840521A1 Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation |
| 01/03/2013 | CA2840491A1 Topical ophthalmological pharmaceutical composition containing sorafenib |
| 01/03/2013 | CA2840480A1 Antipruritic agent |
| 01/03/2013 | CA2840413A1 Methods and compositions for inhibition of bone resorption |
| 01/03/2013 | CA2840396A1 Amido-pyridyl ether compounds and compositions and their use against parasites |
| 01/03/2013 | CA2840393A1 Methods of treatment using allosteric processing inhibitors for matrix metalloproteinases |
| 01/03/2013 | CA2840329A1 Topical ophthalmological pharmaceutical composition containing regorafenib |
| 01/03/2013 | CA2840315A1 Solid forms and salts of tetrahydro-pyrido-pyrimidine derivatives |
| 01/03/2013 | CA2840211A1 Method of administration and treatment |
| 01/03/2013 | CA2840155A1 Esters for treatment of ocular inflammatory conditions |
| 01/03/2013 | CA2840152A1 Esters for treatment of ocular inflammatory conditions |
| 01/03/2013 | CA2840143A1 Composition comprising inhibitors of irs-1 and of vegf |
| 01/03/2013 | CA2840060A1 Bridged bicyclic compounds for the treatment of bacterial infections |
| 01/03/2013 | CA2840013A1 Selective glycosidase inhibitors and uses thereof |
| 01/03/2013 | CA2839869A1 Anti-erbb3 antibobies in combination with paclitaxel for treatment of gynecological cancers |
| 01/03/2013 | CA2839655A1 Novel inhibitor compounds of phosphodiesterase type 10a |